ZIOPHARM Oncology, Inc. (ZIOP.OB) Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
11/6/2009
More...
|
Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
11/6/2009
More...
|
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
11/6/2009
More...
|
Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting
11/6/2009
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Presents Interim Data From a Phase 1/2 Clinical Trial of TH-302 at Sarcoma Meeting
11/6/2009
More...
|
XOMA (US) LLC (XOMA) Expands Development Strategy for XOMA 052 to Include Cardiovascular Diseases
11/6/2009
More...
|
Genetix Pharmaceuticals, Inc. Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)
11/6/2009
More...
|
Puredel Limited Release: Ossulin(TM) Oral Insulin Data to be Presented at The San Francisco Diabetes Congress on November 6, 2009
11/6/2009
More...
|
Chimerix, Inc. Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
11/6/2009
More...
|
NexBio, Inc. Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses
11/6/2009
More...
|
EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus
11/6/2009
More...
|
PPD, Inc. (PPDI) Completes Acquisition of Excel PharmaStudies
11/6/2009
More...
|
RiskMetrics Recommends Stockholders Vote “FOR” Life Sciences Research, Inc. (LSRI.OB)/Lion Holdings Merger
11/6/2009
More...
|
Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus
11/6/2009
More...
|
Theravance, Inc. (THRX) and Astellas Pharma Inc. Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
11/6/2009
More...
|
BioMarin Pharmaceutical Inc. (BMRN): United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food
11/6/2009
More...
|
Biostar Pharmaceuticals, Inc. (BSPM) Announces Closing of a $3.6 Million Equity Financing
11/6/2009
More...
|
Delisting of Securities of Hana Biosciences, Inc. (HNAB) From The NASDAQ Stock Market
11/6/2009
More...
|
Locus Pharmaceuticals, Inc. Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris
11/6/2009
More...
|
Althea Technologies, Inc. Adds Formulation Development to Its Integrated Offering of Contract Services
11/6/2009
More...
|
Achillion Pharmaceuticals, Inc. Reports Third Quarter Results
11/6/2009
More...
|
Aceto Corporation Announces Fiscal 2010 First Quarter Results of Operations
11/6/2009
More...
|
Athersys, Inc. Reports 2009 Third Quarter Results
11/6/2009
More...
|
Alkermes (ALKS) Reports Second Quarter Fiscal 2010 Financial Results
11/6/2009
More...
|
Sucampo Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of 2009
11/6/2009
More...
|
Emergent BioSolutions (EBS) Reports Financial Results for Third Quarter and First Nine Months of 2009
11/6/2009
More...
|
Ardea Biosciences, Inc. Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
11/6/2009
More...
|
Aastrom Biosciences, Inc. (ASTM) Reports First Quarter Fiscal Year 2010 Financial Results
11/6/2009
More...
|
BioSpecifics Technologies Corporation (BSTC) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
BioMimetic Therapeutics, Inc. (BMTI) Reports 2009 Third Quarter Earnings Results
11/6/2009
More...
|
Bioniche Pharma Ltd. Reports Fiscal 2010 First Quarter Results And Achievement of First Milestone Under Licensing Agreement
11/6/2009
More...
|
BIOLASE Technology, Inc. (BLTI) Reports Third Quarter, Nine-Month Results
11/6/2009
More...
|
Cadence Pharmaceuticals, Inc. Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
BioNovo, Inc. (BNVI) Announces Third Quarter 2009 Highlights and Financial Results
11/6/2009
More...
|
Celsion Corporation (CLN) to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009
11/6/2009
More...
|
DUSA Pharmaceuticals (DUSA) Reports Third Quarter 2009 Corporate Highlights and Financial Results Q3 Domestic PDT
11/6/2009
More...
|
Evotec AG (EVTG.F) to Report Third Quarter 2009 Results on 12 November 2009
11/6/2009
More...
|
GTC Biotherapeutics (GTCB) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
GenVec Inc. (GNVC) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
GeoVax Labs Inc. (GOVX.OB) Provides Third Quarter 2009 Financial Results and Operational Update
11/6/2009
More...
|
Halozyme Therapeutics, Inc. (HALO) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
Immunomedics, Inc. (IMMU) Announces First Quarter Fiscal 2010 Results and Clinical Program Developments
11/6/2009
More...
|
Helix BioMedix, Inc. (HXBM) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
Inhibitex, Inc. (INHX) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
InterMune, Inc. (ITMN) Reports Third Quarter 2009 Financial Results and Business Highlights
11/6/2009
More...
|
Insmed Incorporated (INSM) Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2009
11/6/2009
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Announces Third Quarter 2009 Financial Results -Achieved Record Quarterly Net Product Sales of $30 Million - Raising Revenue Guidance for 2009
11/6/2009
More...
|
Ligand Pharmaceuticals Inc. (LGND) Announces Third Quarter Results
11/6/2009
More...
|
Labopharm (DDS.TO) Reports Results for Third Quarter Fiscal 2009
11/6/2009
More...
|
Life Sciences Research, Inc. (LSRI.OB) Announces Third Quarter Results
11/6/2009
More...
|
Maxygen, Inc. (MAXY) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
Nabi Biopharmaceuticals (NABI) Announces Third Quarter 2009 Financial Results
11/6/2009
More...
|
Neurogen Corporation (NRGN) Announces Third Quarter 2009 Financial Results and Updates Operations
11/6/2009
More...
|
Novavax, Inc. (NVAX) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
NeurogesX, Inc. Reports Third Quarter 2009 Results Conference Call Today at 9am ET
11/6/2009
More...
|
Novadaq Corp. Expands Q3-09 Financial Results Conference Call to Include Live Webcast
11/6/2009
More...
|
Osteotech, Inc. (OSTE) Reports Third Quarter 2009 Financial Results Company Achieves Sequential and Year-Over-Year U.S. Sales Growth In Base Business 2009 Guidance Updated Call on November 6, 2009 at 9:00 a.m. EST
11/6/2009
More...
|
OncoGenex Pharmaceuticals Inc. Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
Par Pharmaceutical, Inc. Reports EPS of $0.76 for Third Quarter 2009 Achieves Record Quarterly Gross Margin of $92 Million
11/6/2009
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call
11/6/2009
More...
|
Somaxon Pharmaceuticals, Inc. Reports 2009 Third Quarter Financial Results
11/6/2009
More...
|
Stellar Pharmaceuticals Inc. (SLX.V)'s Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability
11/6/2009
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
Transcept Pharmaceuticals, Inc. (TSPT) to Report Third Quarter 2009 Results and Host Conference Call on November 12
11/6/2009
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Reports Third Quarter and Nine Months 2009 Financial Results
11/6/2009
More...
|
Targacept, Inc. (TRGT) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
ThermoGenesis (KOOL) Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line
11/6/2009
More...
|
ZymoGenetics, Inc. (ZGEN) Reports Third Quarter 2009 Financial Results
11/6/2009
More...
|
Amarin Corporation PLC (AMRN) Appoints John F. Thero as Chief Financial Officer
11/6/2009
More...
|
TARIS Biomedical Appoints Julie Lekstrom Himes, MD, to CMO Post
11/6/2009
More...
|
EpiCept Corporation (EPCT) Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
11/6/2009
More...
|
Emisphere Technologies, Inc. (EMIS) Appoints Tim Rothwell to the Board of Directors
11/6/2009
More...
|
Washington Biotechnology & Biomedical Association’s New “Healthcare Economics in WA” Breaking News is Powered by MedIntelliBase(R) Intelligence Services
11/6/2009
More...
|
Purdue Research Foundation to Recognize 32 Faculty and Staff Entrepreneurs, Inventors
11/6/2009
More...
|
Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council
11/6/2009
More...
|
Laboratory Corporation of America Holdings (LabCorp) (LH) is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference
11/6/2009
More...
|
Sucampo Pharmaceuticals, Inc. Invites Investors to Listen to Webcast of Presentation at Credit Suisse Conference
11/6/2009
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) to Present at the 18th Annual Credit Suisse Healthcare Conference
11/6/2009
More...
|
BioScrip (BIOS) to Present at Credit Suisse 18th Annual Healthcare Conference
11/6/2009
More...
|
King Pharmaceuticals®, Inc. to Present at Credit Suisse Healthcare Conference
11/6/2009
More...
|